Mayo Clinic researchers getting closer to predicting Alzheimer's

Researchers working with mice have identified biological red flags that show who's more prone to developing the brain disease. The Minnesota Alzheimer's Association is hopeful but cautions "People aren't mice."
Author:
Publish date:

Researchers working with mice have identified biological red flags that show who's more prone to developing the brain disease. The Minnesota Alzheimer's Association is hopeful but cautions "People aren't mice."

Next Up

Related

Mayo Clinic study says hepatitis C behind rise in liver cancer

Researchers are calling for more screening for the disease after a new study shows scarring from the infection can develop into liver cancer. MPR reports the study could have particular impact on the Somali community, where hepatitis C is more prevalent than suspected.

Mayo researchers return from Mt. Everest

Two Mayo Clinic researchers spent 10 days conducting physical tests on themselves and about 20 climbers at the base camp for Mt. Everest. The testing at 17,500 feet sheds light on how the body reacts to high altitudes, which mimics conditions that patients suffer from heart disease, obesity and aging.

Mayo Clinic signs research partnership with India

The Rochester clinic has agreed to partner its research efforts with the country in the hopes of speeding up medical breakthroughs. Mayo Clinic already had research agreements with companies in Sweden and the Czech Republic.

Mayo Clinic to acquire Fairview hospital in Red Wing

Rochester-based Mayo Clinic and Minneapolis-based Fairview Health Services have signed a tentative agreement to transfer control of Red Wing Medical Center. Mayo Clinic Health System hopes to assume operations by July 1. The deal follows months of discussion.

Mayo Clinic wins major patent victory

The Supreme Court sided unanimously with Mayo in a patent dispute with California-based Prometheus Laboratories. The clinic had used a blood test developed by Prometheus until 2004, when it developed its own in-house test. Prometheus sued for patent infringement, but Mayo argued that using test to measure a natural bodily process is not patent eligible.